0001014108-20-000140.txt : 20201208 0001014108-20-000140.hdr.sgml : 20201208 20201208124136 ACCESSION NUMBER: 0001014108-20-000140 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201208 DATE AS OF CHANGE: 20201208 EFFECTIVENESS DATE: 20201208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bond Biosciences, Inc. CENTRAL INDEX KEY: 0001824224 IRS NUMBER: 810933527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-379748 FILM NUMBER: 201374855 BUSINESS ADDRESS: STREET 1: 555 MADISON AVENUE STREET 2: SUITE 1201 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 650-804-2139 MAIL ADDRESS: STREET 1: 555 MADISON AVENUE STREET 2: SUITE 1201 CITY: NEW YORK STATE: NY ZIP: 10022 D/A 1 primary_doc.xml X0708 D/A LIVE 0001824224 Bond Biosciences, Inc. 555 MADISON AVENUE SUITE 1201 NEW YORK NY NEW YORK 10022 650-804-2139 DELAWARE Fetterex Biopharma, Inc. None Corporation true 2015 Michael A. Riley 555 Madison Avenue Suite 1201 New York NY NEW YORK 10022 Executive Officer Director Timothy Opler 555 Madison Avenue Suite 1201 New York NY NEW YORK 10022 Director Cory Berkland 555 Madison Avenue Suite 1201 New York NY NEW YORK 10022 Executive Officer Director Other Health Care Decline to Disclose 06b true 0001014108-20-000122 2020-10-23 false true true true false 1 CIM Securities, LLC 120852 None None 275 Madison Avenue 39th Floor New York NY NEW YORK 10022 AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA IL ILLINOIS KS KANSAS ME MAINE MI MICHIGAN MS MISSISSIPPI NE NEBRASKA NJ NEW JERSEY NY NEW YORK ND NORTH DAKOTA PA PENNSYLVANIA TX TEXAS UT UTAH WA WASHINGTON WI WISCONSIN false 6000000 4999991 1000009 false 57 349999 0 273000 false Bond Biosciences, Inc. /s/Michael A. Riley Michael A. Riley Secretary 2020-12-08